within Pharmacolibrary.Drugs.ATC.A;

model A06AD02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.04,
    Cl             = 0.1,
    adminDuration  = 600,
    adminMass      = 0.4,
    adminCount     = 1,
    Vd             = 0.0003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Magnesium oxide is an inorganic compound used as a dietary supplement in individuals with magnesium deficiency, and as an antacid and laxative. It is commonly employed for short-term relief of heartburn, dyspepsia, and constipation. Magnesium oxide remains in use and is approved in multiple countries for these indications.</p><h4>Pharmacokinetics</h4><p>Estimated oral pharmacokinetic parameters for healthy adults. No published source with detailed compartmental PK parameters; magnesium oxide is poorly absorbed when administered orally and acts primarily in the gastrointestinal tract.</p><h4>References</h4><ol><li><p>Lindberg, JS, et al., &amp; Pak, CY (1990). Magnesium bioavailability from magnesium citrate and magnesium oxide. <i>Journal of the American College of Nutrition</i> 9(1) 48–55. DOI:<a href=&quot;https://doi.org/10.1080/07315724.1990.10720349&quot;>10.1080/07315724.1990.10720349</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2407766/&quot;>https://pubmed.ncbi.nlm.nih.gov/2407766</a></p></li><li><p>Kashihara, Y, et al., &amp; Ieiri, I (2019). Effects of magnesium oxide on pharmacokinetics of L-dopa/carbidopa and assessment of pharmacodynamic changes by a model-based simulation. <i>European journal of clinical pharmacology</i> 75(3) 351–361. DOI:<a href=&quot;https://doi.org/10.1007/s00228-018-2568-4&quot;>10.1007/s00228-018-2568-4</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30382297/&quot;>https://pubmed.ncbi.nlm.nih.gov/30382297</a></p></li><li><p>Werner, T, et al., &amp; Cibulka, M (2019). Assessment of bioavailability of Mg from Mg citrate and Mg oxide by measuring urinary excretion in Mg-saturated subjects. <i>Magnesium research</i> 32(3) 63–71. DOI:<a href=&quot;https://doi.org/10.1684/mrh.2019.0457&quot;>10.1684/mrh.2019.0457</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32162607/&quot;>https://pubmed.ncbi.nlm.nih.gov/32162607</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A06AD02;
